MedPath

Outpatient Hospitalization of Unaccompanied Patients at Home for Endovascular Treatment of Peripheral Arterial Disease.

Not Applicable
Recruiting
Conditions
Peripheral Arterial Disease
Interventions
Other: 18 months of inclusion of unaccompanied patients
Other: 24 months of inclusion of unaccompanied patients
Other: 12 months of inclusion of unaccompanied patients
Other: 6 months of inclusion of unaccompanied patients
Registration Number
NCT05756491
Lead Sponsor
Fondation Hôpital Saint-Joseph
Brief Summary

In Westernized countries, the prevalence of peripheral arterial disease (PAD) is estimated at 15-20% of subjects over 70 years of age and is increasing considerably because of the aging of the population and the increasing prevalence of diabetes and renal insufficiency. In response to this increase in incidence, vascular surgeons must develop innovative treatments that minimize the use of resources in a context of budgetary constraints, in patients who are increasingly well informed, while maintaining the safety and effectiveness of the procedures performed.

The endovascular technique has several advantages. First, it is a minimally invasive treatment, most often performed under local anesthesia. Secondly, the duration of the procedure and the length of hospitalization are reduced. In addition, the peri-operative morbidity and mortality is extremely low.

In France, for many years, public health policies have encouraged the development of outpatient hospitalization. Endovascular treatment allows the development of outpatient care. The French Society of Vascular and Endovascular Surgery (SCVE) was the first European society to publish recommendations concerning the outpatient management of endovascular treatment of PAD. These recommendations aim to promote the development of outpatient treatment by providing a framework for practitioners wishing to offer this type of management.

Concerning the patient and according to the SCVE recommendations, all types of occlusive arterial lesions of the lower limbs can be managed on an outpatient basis and only patients with severe comorbidities are excluded from this type of hospitalization. In addition, various studies have shown the safety of outpatient hospitalization for PAD. The absence of an accompanying person on the night following the procedure is considered an exclusion criterion for outpatient care.

The objective of this Stepped-wedge Cluster Randomized Controlled Trial is to increase the use of outpatient hospitalization for endovascular treatment of PAD by proposing a care pathway adapted to people without an accompanying person on the night of the procedure at home.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • For all patients, the inclusion criteria are:
  • Patient with symptomatic PAD (Rutherford 1-5) requiring endovascular revascularization that can be performed on an outpatient basis
  • Procedure listed in the Common Classification of Medical Procedures
  • Patient with a good understanding of the constraints of the study
  • Patient with an ASA score of 1 to 3 (stable)
  • Patient registered with the social security system
  • Patient living less than 1 hour by car from the care facility or from a care facility able to care for this type of patient
  • Patient willing to remain hospitalized if necessary

For accompanied patients only:

  • Patient does not object to the processing of his or her data

Only for isolated patients:

  • Patient with free, informed and written consent
  • Patient agreeing to wear the remote monitoring device at discharge from the outpatient revascularization hospitalization
  • Patient agreeing to the processing of his or her personal data with the remote monitoring provider
  • Patient not living in an area not served by a cell phone network (white zone)
Exclusion Criteria
    • Disorders of hemostasis
  • Acute ischemia of the lower limbs
  • Patient already included in ABALONE (2nd inclusion impossible)
  • Patient already included in a type 1 interventional research protocol
  • Patient under guardianship or curatorship
  • Patient deprived of liberty
  • Patient under legal protection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental: Group218 months of inclusion of unaccompanied patientsIn group 2: 5 other centers will be randomized for the inclusion of unaccompanied patients for 18 months
Experimental: Group124 months of inclusion of unaccompanied patientsIn group 1: 5 centers will be randomized for the inclusion of unaccompanied patients for 24 months
Experimental: Group312 months of inclusion of unaccompanied patientsIn group 3: 5 other centers will be randomized for the inclusion of unaccompanied patients for 12 months
Experimental: Group46 months of inclusion of unaccompanied patientsIn group 4: 5 other centers will be randomized for the inclusion of unaccompanied patients for 6 months
Primary Outcome Measures
NameTimeMethod
Outpatient Hospitalization Rate for Endovascular Treatment of PAD at the End of the Procedure Period30 month
Secondary Outcome Measures
NameTimeMethod
Assessment of patient anxiety using the HAS anxiety questionnaireDay 7
Number of postoperative complications requiring re-hospitalization1 month
Functional improvement at 1 month as assessed by the Rutherford classification1 month

Trial Locations

Locations (20)

Centre Hospitalier de Béziers,

🇫🇷

Béziers, France

Chu Cote de Nacre

🇫🇷

Caen, France

Hopital Le Bocage,

🇫🇷

Dijon, France

Hopital Prive Dijon Bourgogne

🇫🇷

Dijon, France

Chu Jean Minjoz

🇫🇷

Besançon, France

Hopital Universitaire Ambroise Paré,

🇫🇷

Boulogne Billancourt, France

CHRU Cavale Blanche

🇫🇷

Brest, France

Hôpital Universitaire Gabriel Montpied

🇫🇷

Clermont-Ferrand, France

Hopital Prive Du Confluent

🇫🇷

Nantes, France

Pôle médical du Grand large,

🇫🇷

Décines-Charpieu, France

Clinique Mutualiste Porte de L'Orient

🇫🇷

Lorient, France

Chu de Nice,

🇫🇷

Nice, France

Chu de Nantes

🇫🇷

Nantes, France

Hôpital Saint Joseph

🇫🇷

Paris, France

Clinique de L'Europe

🇫🇷

Rouen, France

Polyclinique Francheville,

🇫🇷

Périgueux, France

Centre Hospitalier Privé SAINT GREGOIRE

🇫🇷

Saint Gregoire, France

Centre Hospitalier Yves Le Foll-

🇫🇷

Saint-Brieuc, France

Clinique Esquirol-Saint-Hilaire,

🇫🇷

Saint-Hilaire, France

Médipôle Lyon Villeurbanne,

🇫🇷

Villeurbanne, France

© Copyright 2025. All Rights Reserved by MedPath